Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Hyderabad India; April 11, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, announced the

Continue ReadingDr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy’s enters into exclusive distribution partnership with Sanofi Healthcare India Private Limited for their vaccine brands in India

Hyderabad India; March 28, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical company, today announced

Continue ReadingDr. Reddy’s enters into exclusive distribution partnership with Sanofi Healthcare India Private Limited for their vaccine brands in India

Dr. Reddy’s Announces Launch of D2C E-Commerce Website ‘Celevida Wellness’ for Diabetes

India; October 26, 2023 – Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, today announced the launch of its first direct-to-consumer (D2C) e-commerce website ‘Celevida Wellness’ for diabetes patients by

Continue ReadingDr. Reddy’s Announces Launch of D2C E-Commerce Website ‘Celevida Wellness’ for Diabetes

Copyright © 2021 | Pulse Expert Tech | ​Shreyas WebMedia Solutions Pvt. Ltd.